← Back to Clinical Trials
Recruiting NCT07167121

NCT07167121 Predictive Validity of the Chelsea Critical Care Physical Assessment Tool (CPAx) for Regaining Autonomy Three Months After ICU Discharge

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07167121
Status Recruiting
Phase
Sponsor Centre Hospitalier Intercommunal Elbeuf-Louviers-Val de Reuil
Condition ICU Acquired Weakness
Study Type OBSERVATIONAL
Enrollment 25 participants
Start Date 2025-09-01
Primary Completion 2026-08-01

Trial Parameters

Condition ICU Acquired Weakness
Sponsor Centre Hospitalier Intercommunal Elbeuf-Louviers-Val de Reuil
Study Type OBSERVATIONAL
Phase N/A
Enrollment 25
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-09-01
Completion 2026-08-01
Interventions
CPAx

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This single-center observational study aims to explore the relationship between the CPAx score (Chelsea Critical Care Physical Assessment Tool), measured at ICU discharge, and the 6-minute walk test (6MWT) distance performed 3 months after discharge. The study targets patients who experienced prolonged mechanical ventilation and were admitted to the ICU at CHI Elbeuf-Louviers-Val-de-Reuil. Eligible participants must show signs of malnutrition, muscular weakness, or post-traumatic stress symptoms. Data collection includes the CPAx score, 6MWT distance, MRC score, and relevant clinical and demographic information. The primary objective is to determine whether the CPAx score can predict long-term functional recovery and guide post-ICU rehabilitation strategies. Participants will be evaluated during routine follow-up in the day hospital. This non-interventional study poses minimal risk to participants.

Eligibility Criteria

Inclusion Criteria: * Patient affiliated with, or entitled to benefit from, a French social security system. * Patient who has received clear and comprehensive information about the study and has signed the informed consent form together with the investigator. * Age ≥ 18 years. * Having received at least 48 hours of invasive mechanical ventilation. * Previous hospitalization in the intensive care unit (ICU) at CHI Elbeuf-Louviers-Val-de-Reuil. * Prescription of physiotherapy during the ICU stay. * Eligible for the 3-month post-ICU follow-up in the day hospital based on at least one of the following criteria: * Mechanical ventilation or catecholamine treatment (norepinephrine) for ≥ 5 days; * Weight loss ≥ 5% during hospitalization (criterion for malnutrition); * Significant muscle weakness (MRC score \< 28/60); * Presence of post-traumatic stress symptoms related to ICU stay (evaluated by the psychologist). * Ability to walk (with or without assistive devices) prior to ICU admission. E

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology